Twist Bioscience to Present at Upcoming Virtual Investor Conferences

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming virtual investor conferences: Baird 2020 Virtual Global Healthcare Conference on Thursday, September 10th at 2:00 p.m. ET 2

Click to view original post